Skip to content
OpenCapital
Get started

Bausch Health Companies BHC Current ratio

Current ratio at other companies

PBH
Prestige Consumer HealthcarePBH
3.6×-0.6×
Bausch + Lomb logo
Bausch + LombBLCO
1.5×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
1×-0.2×
AbbVie logo
AbbVieABBV
0.8×0.0×
Organon logo
OrganonOGN
2×+0.3×
HRO
HarrowHROW
2.5×+1.6×

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—

Where this comes from

Calculated from Bausch Health Companies’s reported figures.

total current assets/total current liabilities=1.3×

Based on the most recent quarter.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's current ratio?
Bausch Health Companies (BHC) reported current ratio of 1.3× in Q1 2026.
How has Bausch Health Companies's current ratio changed year-over-year?
Bausch Health Companies's current ratio decreased by 2.0% year-over-year, from 1.3× to 1.3×.
What is the long-term trend for Bausch Health Companies's current ratio?
Over 5 years (2020 to 2025), Bausch Health Companies's current ratio has grown at a 6.3% compound annual growth rate (CAGR), from 1.1× to 1.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.